BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for Feb. 10, 2026

Feb. 10, 2026
New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: United Imaging Healthcare.
Read More

Financings for Feb. 10, 2026

Feb. 10, 2026
Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: Adlai Nortye.
Read More

Regulatory actions for Feb. 10, 2026

Feb. 10, 2026
Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Astrazeneca, Daiichi Sankyo, Everest Medicines, Kelun-Biotech, Neurophet.
Read More

Other news to note for Feb. 10, 2026

Feb. 10, 2026
Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: 48Hour Discovery, Advancell, Arctic Vision, Biodexa, Biomica, Eisai, Eli Lilly, Everest Medicines,  Evogene, Golden Age Health, Henlius, Lishan, MDCO Technology, Micot, Newsoara, Otsuka, Phase Scientific, Tenacia, Vtv, Zonsen Peplib.
Read More

Regulatory actions for Feb. 9, 2026

Feb. 9, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Everest, GSK, Kelun-Biotech, Kite, Neurophet, P+F Products and Features, Partner Therapeutics, Pfizer, Spinal Resources, Zimmer Biomet.
Read More

Other news to note for Feb. 9, 2026

Feb. 9, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Cerenovus, Clearmind, Coeptis, Diagnoly, GE Healthcare, Guard, Iovance, Lakeshore, Nugen, Polyrizon.
Read More

In the clinic for Feb. 9, 2026

Feb. 9, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Aro, Bayer, Denali, Field Medical, Genesys Spine, Hoya Vision, Neovac, Pulse, Roivant, Spruce, Uniqure.
Read More

Financings for Feb. 9, 2026

Feb. 9, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Satellos, Veradermics.
Read More

Appointments and advancements for Feb. 9, 2026

Feb. 9, 2026
New hires and promotions in the biopharma and med-tech industries, including: Cleveland, Insilico, K36, Tharimmune.
Read More

Biggest gainers and losers for Feb. 2-6, 2026

Feb. 9, 2026
The top 10 biopharma stock gainers and losers for the week.
Read More
Previous 1 2 … 53 54 55 56 57 58 59 60 61 … 1808 1809 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

    BioWorld Science
    Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing